BioMarin Pharmaceutical, Inc. (BMRN)
51.81
-1.43
(-2.69%)
USD |
NASDAQ |
May 15, 16:00
51.74
-0.07
(-0.14%)
After-Hours: 20:00
BioMarin Pharmaceutical EPS Diluted (Quarterly) : 0.5431 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| Mirum Pharmaceuticals, Inc. | -13.43 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 105.53M |
| Revenue (Quarterly) | 778.62M |
| Total Expenses (Quarterly) | 673.09M |
| Enterprise Value | 9.238B |
| Gross Profit Margin (Quarterly) | 74.38% |
| Profit Margin (Quarterly) | 13.55% |
| Earnings Yield | 2.64% |
| Operating Earnings Yield | 7.30% |
| Normalized Earnings Yield | 5.293 |